This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
2 Sep 2011

Pfizer Extends Tender Offer to Acquire Icagen

Pfizer's subsidiary, Eclipse Acquisition Corp. , has extended the expiration date of its tender offer for Icagen.

Pfizer Inc. and Icagen, Inc. announced Thursday that Pfizer's wholly-owned subsidiary, Eclipse Acquisition Corp. , has extended the expiration date of its tender offer for all outstanding shares of common stock of Icagen for $6.00 per share, paid to the seller in cash, without interest thereon, less any applicable withholding and transfer taxes.

 

The tender offer is now scheduled to expire at 12:00 midnight, New York City time, at the end of Thursday, September 1, 2011, unless further extended. The tender offer was previously scheduled to expire at 12:00 midnight, New York City time, at the end of Wednesday, August 31, 2011.

 

American Stock Transfer & Trust Company, LLC, the depositary for the tender

Related News